Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy

• Status: Unknown status
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to analysis the different genotype in the idiopathic membranous nephropathy patients which with different therapeutic outcomes after treated by the Comprehensive Treatment Regimen or immunosuppressive agents, and so as to looking for ideal markers to assess appropriate treatment approach and the long-term efficacy.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Shanghai University of Traditional Chinese Medicine
• Treatments: Cyclophosphamide; Cyclosporine; Cyclosporins; Glucocorticoids; Immunosuppressive Agents; Tacrolimus

Criteria

Inclusion Criteria:

• Clinical diagnosis of idiopathic membranous nephropathy

• Chronic Kidney Disease (CKD)≤3 stage（Glomerular Filtration Rate (GFR)≥30ml/min）and 24 hour urinary protein≥3g

• Voluntarily participated in the study and signed an informed consent

Exclusion Criteria:

• Combined life-threatening complications such as serious infection

• Abnormal glucose metabolism

• Patients with malignant tumors or malignancy , HIV infection and a history of mental illness , acute central nervous system disease , serious gastrointestinal diseases,etc

• Pregnancy or breast-feeding women

• Undergoing other clinical trials